Prophylaxis of Thrombosis
AssigneeTranslational Sciences Inc.
InventorGuy L. Reed
Life of this patent
Estimating the term…
Abstract
The invention provides a method and composition for preventing thrombosis and complications associated therewith by targeting Sf2 directly. The invention provides Sf2-deficiency or prophylactic administration of a therapeutic agent, such as a Sf2 antagonist or a Sf2 antibody, markedly reduces thrombus formation that would otherwise be caused due to surgery, immobility, genetic abnormality, cancer, trauma, or other risk factors.
Claims20
A method for preventing thrombus formation or complications associated therewith in an individual in need comprising administering to the individual a thrombus prophylactic amount of a composition comprising a Sf2 antagonist and a pharmaceutically acceptable carrier.
A composition for preventing thrombus formation or complications associated therewith in a patient at risk comprising a thrombus prophylactic amount of a Sf2 antagonist and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.